• About us
  • Contact us
  • Privacy Policy
  • Terms & Conditions
Fund Fluxes
Advertisement
  • Business
  • investing
  • Politics
  • Stocks
No Result
View All Result
  • Business
  • investing
  • Politics
  • Stocks
No Result
View All Result
Fund Fluxes
No Result
View All Result
Home investing

Jindalee Realises $2.75M from Sale of Non-Core Asset

February 25, 2025
in investing
0
Jindalee Realises $2.75M from Sale of Non-Core Asset
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Jindalee Lithium Limited (Jindalee, the Company; ASX: JLL, OTCQX: JNDAF) advises that the Company has sold its shareholding in Dynamic Metals (ASX: DYM, Dynamic), raising $2.75M before costs.

Dynamic was formerly a Jindalee subsidiary which held Jindalee’s Australian exploration assets. Dynamic was spun out of the Company in January 2023 following a $7M IPO which included a priority entitlement to Jindalee shareholders1, leaving Jindalee as a pure play US lithium company focussed on the 100% owned McDermitt Project (McDermitt), one of the largest lithium deposits in the US and of global significance.

In mid-November 2024 Jindalee announced the results of a Pre-Feasibility Study (PFS) on McDermitt2. The PFS confirmed a 63 year life with the Project producing 1.8Mt Lithium Carbonate at C1 costs of US$8,670/t for the first 40 years and a 5 year payback. The PFS also noted excellent potential to reduce capital and operating costs as well as increase production at McDermitt.

Priority activities following completion of the PFS include engagement with potential funding partners and US Government agencies, together with investigation of opportunities to improve Project economics, permitting and community engagement. The proceeds from the Dynamic sale will enable these activities to be accelerated.

Jindalee’s CEO Ian Rodger commented‘This transaction is firmly aligned with our strategy of advancing McDermitt while preserving shareholder value. At a time when many lithium companies are struggling to raise capital, Jindalee’s ability to unlock funding from a non-core asset enables us to accelerate project development in a less dilutive way. History shows that projects advanced during downturns are best positioned to capture the upswing, and with lithium prices at unsustainable levels, a supply crunch is inevitable. This funding provides us the runway to progress key catalysts—including engagement with potential funding partners and US government agencies, project optimisation, and advancing permitting and community engagement. As one of the most advanced sedimentary lithium projects in the US, McDermitt is strategically positioned to benefit from the policy priorities of the new administration as the US moves to secure domestic supply of critical minerals.’

Click here for the full ASX Release

This post appeared first on investingnews.com

Previous Post

Chinese Market Approval for WOA’s Lupin Protein Isolate

Next Post

Virka Project Sampling Returns High-Grade Mineralisation

Next Post
Virka Project Sampling Returns High-Grade Mineralisation

Virka Project Sampling Returns High-Grade Mineralisation

    Sign up for our newsletter to receive the latest insights, updates, and exclusive content straight to your inbox! Whether it's industry news, expert advice, or inspiring stories, we bring you valuable information that you won't find anywhere else. Stay connected with us!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent News

    Navigating Earnings: Three Stocks, Three Different Stories

    Navigating Earnings: Three Stocks, Three Different Stories

    May 13, 2025
    Unlock the Power of StockCharts’ NEW Market Summary Dashboard | Walkthrough & Tips

    Unlock the Power of StockCharts’ NEW Market Summary Dashboard | Walkthrough & Tips

    May 13, 2025
    Senate parliamentarian: Who is the unelected official getting say on Trump’s ‘big, beautiful bill?’

    Senate parliamentarian: Who is the unelected official getting say on Trump’s ‘big, beautiful bill?’

    May 13, 2025
    President Trump takes on ‘Big Pharma’ by signing executive order to lower drug prices

    President Trump takes on ‘Big Pharma’ by signing executive order to lower drug prices

    May 13, 2025

    Disclaimer: fundfluxes.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.



    Copyright © 2024 fundfluxes.com | All Rights Reserved

    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Recent News

    Navigating Earnings: Three Stocks, Three Different Stories

    Navigating Earnings: Three Stocks, Three Different Stories

    May 13, 2025
    Unlock the Power of StockCharts’ NEW Market Summary Dashboard | Walkthrough & Tips

    Unlock the Power of StockCharts’ NEW Market Summary Dashboard | Walkthrough & Tips

    May 13, 2025
    Senate parliamentarian: Who is the unelected official getting say on Trump’s ‘big, beautiful bill?’

    Senate parliamentarian: Who is the unelected official getting say on Trump’s ‘big, beautiful bill?’

    May 13, 2025
    No Result
    View All Result
    • Business
    • investing
    • Politics
    • Stocks

    Copyright © 2024 pinnacleofinvestment.com | All Rights Reserved